Table 1.

Characteristics of the HCV cohort and the non-HCV comparison cohort.

HCV cohortComparison cohort
Total in the study cohort52,853523,649
Total observed person-years589,2946,395,003
Mean observed person-years (SD)11 (7.15)12 (7.28)
Deceased (%)12,748 (24.1)39,292 (7.5)
Male sex (%)35,414 (67.0)351,009 (67.0)
Mean age at notification (SD)40 (13.62)40 (13.67)
Year of birth (% by cohort)
 <19301,227 (2.32)12,318 (2.35)
 1930–19454,061 (7.68)40,657 (7.76)
 1945–196019,588 (37.06)194,051 (37.06)
 1960–197516,707 (31.61)165,001 (31.51)
 >197511,270 (21.32)111,622 (21.32)
Country of origin (% by cohort)
 Nordic countries including Sweden46,174 (87.36)426,953 (81.53)
 Other6,679 (12.64)96,696 (18.47)
Diagnosed with liver cancer (% by cohort)1,609 (3.04)408 (0.08)
Males with liver cancer diagnoses1,303 (3.68)297 (0.08)
Females with liver cancer diagnoses306 (1.75)111 (0.06)
Mean age at liver cancer diagnosis (SD)61 (8.90)63 (12.59)
Liver cancer diagnoses by year of birth (% in cohort)
 <1930115 (7.15)60 (14.71)
 1930–1945413 (25.67)134 (32.84)
 1945–1960976 (60.66)173 (42.40)
 1960–1975102 (6.34)35 (8.58)
 >19753 (0.19)6 (1.47)